Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.45 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.42 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | HRH1 | P35367 | 1/20 | 0.42 |
| ▸ | DRD3 | P35462 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | GCLC | P48506 | 2/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.36 |
| ▸ | PPARG | P37231 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19825149 | 0.85 | CHRM1 (0.38) | CA2MAPK1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL23244999 | 0.84 | CA2 (0.50) | CA2MAPK1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL5389894 | 0.82 | CHRM1 (0.62) | CA2MAPK1SLC1A3SLC1A2SLC1A1 | |
| Ethylene SCHEMBL28464372 | 0.80 | CHRM1 (0.35) | CA2MAPK1SLC1A1TDP1CHRM1 | |
| SCHEMBL3914888 | 0.80 | CA2 (0.56) | CA2MAPK1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL29745595 | 0.80 | HTT (0.37) | CA2MAPK1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL4414201 | 0.79 | CA2 (0.48) | CA2MAPK1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL20788560 | 0.79 | USP2 (0.38) | CA2MAPK1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL16194041 | 0.79 | CA2 (0.32) | CA2MAPK1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL28561696 | 0.79 | CA2 (0.61) | CA2MAPK1SLC1A3SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3523280-B1 | PROCESSES AND INTERMEDIATES FOR PREPARING A BTK INHIBITOR | JANSSEN PHARMACEUTICA NV (BE) | 2026-03-11 | — | — | EP | claimed |
| CN-117946303-A | Catalyst, preparation method thereof, method for regulating and controlling ethylene polymerization kinetics behavior and application | 中国石油化工股份有限公司 | 2024-04-30 | — | — | CN | claimed |
| US-20220328881-A1 | Electrolyte Enabling Stable Extended Cycling Under Extreme Conditions | US ENERGY (US) | 2022-10-13 | — | — | US | claimed |
| CN-114941015-A | Method for producing secondary alcohol with high mirror image selectivity | 深圳艾欣达伟医药科技有限公司 | 2022-08-26 | — | — | CN | claimed |
| CN-113474315-A | Method for producing secondary alcohol with high mirror image selectivity | 深圳艾欣达伟医药科技有限公司 | 2021-10-01 | — | — | CN | claimed |
| CN-110556509-A | Method for performing surface protection and passivation treatment on metallic lithium cathode by using fluorine-containing organic matter, product and application | NANJING UNIVERSITY OF TECHNOLOGY | 2019-12-10 | — | — | CN | claimed |
| EP-1470220-B1 | SELECTIVE ENZYMATIC ESTERIFICATION AND SOLVOLYSIS OF EPIMERIC VITAMIN D ANALOG AND SEPARATION OF THE EPIMERS | TEVA PHARMA (IL) | 2011-10-05 | — | — | EP | claimed |
| EP-1490501-B1 | ENZYMATIC RESOLUTION OF PROPYLENE GLYCOL ALKYL (OR ARYL) ETHERS AND ETHER ACETATES | REDDY S LAB EU LTD DR (GB) | 2010-05-26 | — | — | EP | claimed |
| EP-1418237-A2 | Anti-Kazlauskas lipases | Bayer Chemicals AG (DE) | 2004-05-12 | — | — | EP | claimed |
| WO-2025072539-A1 | AMINO ACID COMPOUNDS WITH NITROGEN LINKERS AND USES THEREOF | PLIANT THERAPEUTICS, INC. (US) | 2025-04-03 | — | — | WO | disclosed |
| CN-118638450-A | Medical endoscope antifogging agent and application thereof | 辉擎医疗科技(嘉兴)有限公司 | 2024-09-13 | — | — | CN | disclosed |
| US-20240270742-A1 | SUBSTITUTED AMINO ACIDS AS INTEGRIN INHIBITORS | PLIANT THERAPEUTICS INC (US) | 2024-08-15 | — | — | US | disclosed |
| CN-117946303-A | Catalyst, preparation method thereof, method for regulating and controlling ethylene polymerization kinetics behavior and application | 中国石油化工股份有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-117946304-A | Spherical catalyst component containing fluoroester electron donor, preparation method, catalyst and application thereof in ethylene polymerization | 中国石油化工股份有限公司 | 2024-04-30 | — | — | CN | disclosed |
| US-5270421-A | Sucrose-organic acid units | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 1993-12-14 | — | — | US | disclosed |
| EP-0542996-A4 | SUGAR-BASED POLYMERS | — | 1993-10-20 | — | — | EP | disclosed |
| EP-0542996-A1 | SUGAR-BASED POLYMERS | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 1993-05-26 | — | — | EP | disclosed |
| WO-1992021765-A1 | SUGAR-BASED POLYMERS | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 1992-12-10 | — | — | WO | disclosed |
| WO-1991019002-A1 | A PROCESS FOR CHIRAL ENRICHMENT OF ASYMMETRIC PRIMARY AMINES | CARLBIOTECH LTD. A/S (DK) | 1991-12-12 | — | — | WO | disclosed |
| WO-1991017255-A1 | BIODEGRADABLE SUGAR-BASED POLYMER | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 1991-11-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240270742-A1 | SUBSTITUTED AMINO ACIDS AS INTEGRIN INHIBITORS | ITGB6, ITGA1, ITGB1 | CA2 4386/4885MAPK1 1100/4885SLC1A3 408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.